Press Releases Scancell Holdings plc

Equities

Market Closed - London S.E. Other stock markets 11:35:08 2024-05-02 am EDT			5-day change	1st Jan Change
9.1 ^GBX	-1.62%		-5.21%	-13.33%

Mar. 26	Scancell doses first patient in melanoma-focused trials	AN
Mar. 22	Seneca Growth Capital announces tepid 2023 results	AN

Scancell CEO hails "exciting" high response rate to melanoma treatment	23-09-20	AQ
Scancell : Positive Data for SCIB1, 19th September 2023	23-09-19	PU
Scancell : SCIB1 SCOPE study shows a striking 82% ORR	23-09-19	PU
Scancell : Upcoming SCIB1 data could provide first proof of concept	23-09-06	PU
Scancell Holdings "well-financed" and continuing to pursue deals	23-07-11	AQ
Scancell : Modi-1 successful in first part of Phase I/II trial	23-02-21	PU
Scancell : a leader in antibody and vaccine technology platforms	23-02-15	PU
Scancell : Interim Report 31st October 2022	23-01-25	PU
Scancell : AGM Presentation 2022	22-11-22	PU
Scancell : Notice of Annual General Meeting November 2022	22-10-28	PU
Scancell : A fresh impetus in delivering immune-oncology vaccines	22-04-13	PU
Scancell : Interim Report 31st October 2021	22-01-26	PU
Annual Report 30th April 2021	21-10-29	PU
Scancell : COVIDITY programme to start Phase I in H221	21-06-22	PU
Scancell : H121 results highlight shift to delivery and execution January 2021	21-01-29	PU
Scancell : Interim Report 31st October 2020	21-01-29	PU
Scancell : Redmile funding releases the brakes	20-11-18	PU
Scancell : Notice of Annual General Meeting November 2020	20-10-21	PU
Scancell : Annual Report 30th April 2020	20-10-16	PU
Scancell : Material fund raise means clinical progress in sight	20-07-22	PU

No results for this search